tiprankstipranks
Trending News
More News >
Repositrak (TRAK)
:TRAK
Advertisement

ReposiTrak (TRAK) AI Stock Analysis

Compare
133 Followers

Top Page

TRAK

ReposiTrak

(NYSE:TRAK)

Select Model
Select Model
Select Model
Outperform 74 (OpenAI - 4o)
Rating:74Outperform
Price Target:
$16.50
▲(14.27% Upside)
ReposiTrak's overall stock score is driven by its strong financial performance and positive earnings call, which highlight robust growth and profitability. However, technical analysis indicates bearish momentum, and the high P/E ratio suggests valuation concerns. These factors collectively result in a moderate stock score.
Positive Factors
Revenue Growth
Strong revenue growth of 11% indicates robust demand for ReposiTrak's solutions, enhancing its market position and supporting long-term business expansion.
Cash and Debt Management
Effective cash management and zero bank debt provide financial flexibility and reduce risk, supporting sustainable growth and strategic investments.
Network Expansion and Automation
Leadership in traceability solutions through network expansion and automation enhances competitive advantage and addresses a growing market need.
Negative Factors
Increased Operating Expenses
Rising operating expenses may pressure margins and profitability, potentially impacting the company's ability to invest in growth initiatives.
Impact of Tariffs
Tariffs pose a risk to the food supply chain, which could affect customer spending and demand for ReposiTrak's solutions, impacting future revenue.
Decline in Free Cash Flow Growth
A decline in free cash flow growth may limit the company's ability to fund new projects and return capital to shareholders, affecting long-term financial health.

ReposiTrak (TRAK) vs. SPDR S&P 500 ETF (SPY)

ReposiTrak Business Overview & Revenue Model

Company DescriptionReposiTrak, Inc. is a leading provider of supply chain and regulatory compliance solutions, primarily serving the retail and food sectors. The company focuses on enhancing product traceability, ensuring food safety, and streamlining supply chain operations through its innovative technology platform. ReposiTrak offers a suite of services including product compliance management, supplier risk assessment, and inventory management, catering to a diverse clientele that includes retailers, manufacturers, and distributors.
How the Company Makes MoneyReposiTrak generates revenue through a subscription-based model, where clients pay for access to its software platform and services. Key revenue streams include annual subscriptions for compliance and traceability solutions, transaction fees from the processing of product data, and consulting services aimed at helping businesses optimize their supply chain processes. Additionally, partnerships with major retailers and food industry stakeholders enhance revenue opportunities through shared compliance initiatives and data analytics services, allowing ReposiTrak to expand its market reach and strengthen its service offerings.

ReposiTrak Earnings Call Summary

Earnings Call Date:Sep 29, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Nov 17, 2025
Earnings Call Sentiment Positive
The earnings call reflects a strong financial performance with significant revenue and profitability growth, effective cash management, and positive shareholder returns. However, there are concerns about increased operating expenses and potential future impacts from tariffs.
Q4-2025 Updates
Positive Updates
Revenue Growth for Fiscal Year 2025
Total revenue increased 11% from $20.5 million to $22.6 million. Recurring revenue increased 10% to $22.3 million.
Income and Profitability Increase
Fiscal year income from operations was up 24% to $6.2 million versus $5 million. GAAP net income was $7 million, up 17% versus $6 million last year.
Cash and Debt Management
Cash from operations increased 21% from $7 million to $8.4 million. Total cash increased 14% from $25.2 million to $28.6 million, and the company has 0 bank debt.
Earnings Per Share Growth
Earnings per share for the fiscal year 2025 was $0.36 basic and $0.35 diluted, resulting in a year-over-year EPS growth of 21%.
Deferred Revenue Growth
Deferred revenue increased 30% from $2.4 million to $3.2 million, indicating future growth potential.
Capital Allocation and Shareholder Returns
The company returned more than $25 million in capital to shareholders, including buying back 2.1 million common shares and raising the common stock dividend 3 times since December 2023.
Network Expansion and Automation
The company's network and automation efforts have positioned it as a leader in traceability solutions, with the potential for significant addressable market growth.
Negative Updates
Increased Operating Expenses
Total operating expenses for the fiscal year were up 6%, largely due to investments in development, cybersecurity, and Oracle license fees.
Impact of Tariffs
While not yet significant, there is potential risk from tariffs affecting the food supply chain, which could impact customer spending.
Company Guidance
During ReposiTrak's fiscal fourth quarter and full year earnings call for 2025, key guidance metrics were discussed. The company reported a total revenue increase of 11% year-over-year, reaching $22.6 million, while recurring revenue also rose by 10% to $22.3 million. Setup fees saw a significant jump from $95,000 in fiscal 2024 to over $300,000 in fiscal 2025. Operating expenses increased by 6%, driven by investments in RTN and other development costs. SG&A costs rose by 5%, but the company maintained a high revenue per employee ratio of $343,000, nearly double the industry average. Fiscal year income from operations grew by 24% to $6.2 million, and GAAP net income increased by 17% to $7 million. Earnings per share were reported at $0.36 basic and $0.35 diluted, reflecting a year-over-year growth of 21%. Cash from operations rose by 21% to $8.4 million, and total cash increased by 14% to $28.6 million, with the company holding no bank debt. The guidance emphasized continued growth in recurring revenue and profitability, a focus on efficient automation, and strategic capital allocation aimed at shareholder returns, such as dividends and stock buybacks.

ReposiTrak Financial Statement Overview

Summary
ReposiTrak displays a solid financial performance across all key financial statements. The company has shown strong revenue growth and profitability, supported by a stable and efficient balance sheet and robust cash flow generation. This indicates a well-managed company with a positive outlook in the software industry.
Income Statement
85
Very Positive
ReposiTrak has demonstrated strong revenue growth with a consistent increase from previous periods, showcasing a positive trajectory in the software industry. The company maintains robust profitability with solid gross and net profit margins, indicating efficient cost management and strong market demand. EBIT and EBITDA margins further reflect operational efficiency. The overall income statement presents a stable and growing financial performance.
Balance Sheet
90
Very Positive
The balance sheet of ReposiTrak is strong, with a high equity ratio reflecting a stable financial structure. The debt-to-equity ratio is low, indicating minimal reliance on debt for financing. Additionally, the high return on equity demonstrates the company's effective use of equity capital to generate profits. Overall, the balance sheet showcases financial stability and efficient capital management.
Cash Flow
78
Positive
ReposiTrak's cash flow statement is positive, with strong operating cash flow and free cash flow indicating healthy liquidity. The free cash flow to net income ratio is favorable, suggesting efficient conversion of income into cash. The positive growth rate in free cash flow reflects the company's ability to generate cash from operations, supporting future growth and investment opportunities.
BreakdownTTMDec 2025Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue22.61M22.61M20.45M19.10M18.05M21.01M
Gross Profit18.92M18.92M17.04M14.71M13.98M13.10M
EBITDA7.80M7.51M7.61M7.11M5.38M5.41M
Net Income6.98M6.98M5.96M5.59M4.00M4.12M
Balance Sheet
Total Assets55.33M55.33M51.60M50.58M49.32M55.05M
Cash, Cash Equivalents and Short-Term Investments28.57M28.57M25.15M23.99M21.46M24.07M
Total Debt509.97K509.97K481.02K747.11K2.97M6.70M
Total Liabilities5.81M5.81M4.74M4.70M6.42M9.91M
Stockholders Equity49.52M49.52M46.85M45.88M42.90M45.14M
Cash Flow
Free Cash Flow8.40M8.40M6.89M7.96M6.05M5.08M
Operating Cash Flow8.42M8.42M6.96M8.86M6.10M5.40M
Investing Cash Flow169.00169.00-100.71K-903.19K1.32M-318.87K
Financing Cash Flow-5.01M-5.01M-5.70M-5.43M-10.03M-1.36M

ReposiTrak Technical Analysis

Technical Analysis Sentiment
Negative
Last Price14.44
Price Trends
50DMA
16.34
Negative
100DMA
18.02
Negative
200DMA
19.40
Negative
Market Momentum
MACD
-0.64
Positive
RSI
37.38
Neutral
STOCH
20.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRAK, the sentiment is Negative. The current price of 14.44 is below the 20-day moving average (MA) of 15.96, below the 50-day MA of 16.34, and below the 200-day MA of 19.40, indicating a bearish trend. The MACD of -0.64 indicates Positive momentum. The RSI at 37.38 is Neutral, neither overbought nor oversold. The STOCH value of 20.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TRAK.

ReposiTrak Risk Analysis

ReposiTrak disclosed 26 risk factors in its most recent earnings report. ReposiTrak reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ReposiTrak Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$269.32M42.6114.48%0.52%10.53%21.98%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
58
Neutral
$261.42M-25.48%-28.45%-224.48%
54
Neutral
$232.26M-22.60%-6.88%15.83%
54
Neutral
$246.83M-18.25%-0.73%67.98%
53
Neutral
$232.31M1.32-10.56%11.98%-17.17%497.89%
50
Neutral
$220.34M-28.14%14.78%21.87%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TRAK
ReposiTrak
14.44
-5.52
-27.66%
EGHT
8X8
1.90
-0.18
-8.65%
MKTW
MarketWise
14.76
3.87
35.54%
FRGE
Forge Global Holdings
17.62
-2.48
-12.34%
ONTF
ON24
5.52
-0.70
-11.25%
SMRT
SmartRent
1.45
-0.25
-14.71%

ReposiTrak Corporate Events

Dividends
ReposiTrak Announces Quarterly Dividend Increase
Positive
Jun 23, 2025

On June 20, 2025, ReposiTrak, Inc. announced a quarterly cash dividend of $0.01815 per share, payable on August 14, 2025, to shareholders of record on June 30, 2025. The company also revealed a 10% increase in its quarterly dividend, raising it to $0.02 per share starting with the dividend payable on November 14, 2025, marking the third increase since the dividend’s inception. This move underscores ReposiTrak’s commitment to providing value to its shareholders and may enhance its attractiveness to investors.

The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

DividendsBusiness Operations and StrategyFinancial Disclosures
ReposiTrak Reports 16% Revenue Increase in Q3 2025
Positive
May 19, 2025

ReposiTrak reported a 16% increase in total revenue, reaching $5.9 million for the third fiscal quarter ended March 31, 2025, with a 27% rise in net income. The company attributes this growth to successful cross-selling across its business lines, particularly in traceability, compliance, and supply chain solutions. The onboarding of traceability customers has shifted from retailers to suppliers, expanding the company’s market potential. The company also redeemed preferred shares and declared a quarterly dividend, maintaining a strong cash position with no bank debt.

The most recent analyst rating on (TRAK) stock is a Buy with a $24.00 price target. To see the full list of analyst forecasts on ReposiTrak stock, see the TRAK Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 09, 2025